Finland· FI-REL-REL55110

Accofil

A filgrastim product containing filgrastim, registered in Finland by Abacus Medicine A/S. The same ATC class is registered in 17 of our 19 countries.

ATC L03AA02

Checked against Fimea (Finland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about filgrastimAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Filgrastim is registered in 17 of 19 countries.

Countries holding a registration under ATC L03AA02 (filgrastim), each read from that country’s own register.

This record: Finland, from Fimea (Finland)
10 of them publish a price we can compare per daily dose

Search filgrastim products by name

Filgrastim · ATC L03AA02

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)

Active substance: Filgrastim
Manufacturer: Abacus Medicine A/S
Country: Finland (FI)
ATC code: L03AA02
ATC class: Filgrastim
Defined daily dose: 0.35 mg, P
Reimbursed: Not published by this register
Source register: Fimea (Finland)
Last checked: September 27, 2026

Packs & prices · 1

1 priced

fi_myyntilupa
048854
5 x 0.5 ml
EUR 51.61

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

191 interactions on record for filgrastim.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check filgrastim against other medicines How interaction checks work

Filgrastim · interactions on record

191 records

2 severe
189 moderate

Most severe, free to view

CladribineL01BB04severe
CyclophosphamideL01AA01moderate
ChlorambucilL01AA02moderate
MelphalanL01AA03moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Filgrastim in 18 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All filgrastim products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

Belgium · Neupogen
Germany · Neupogen
Spain · Neupogen
France · Neupogen
United Kingdom (Northern Ireland) · Neupogen, Neupogen Singleject
Ireland · Neupogen, Neupogen Singleject
Iceland · Accofil, Filgrastim Hexal
Italy · Granulokine
Liechtenstein · Accofil, Filgrastim Hexal
Luxembourg · Neupogen
Netherlands · Neupogen, Neupogen Singleject
Norway · Accofil, Filgrastim Hexal
Poland · Neupogen
Sweden · Neupogen
Slovenia · Neupogen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/692cdf10-6362-4553-9933-8e4c46608384
GET /v1/drugs/692cdf10-6362-4553-9933-8e4c46608384?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.35",
  "form": "injektio-/infuusioneste, liuos, esitäytetty ruisku",
  "route": "Ihon alle",
  "ddd_unit": "mg",
  "strength": "30 MU / 0.5 ml",
  "atc_label": "filgrastiimi",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/14/946/008",
  "fimea_rel_id": "REL55110",
  "authorised_at": "2019-07-31"
}

API reference MCP server Plans

See everything about filgrastim.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console